<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref33">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hilgenfeld</surname>
    <given-names>R.</given-names>
   </name>
  </person-group> (
  <year>2014</year>). 
  <article-title>From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design</article-title>. 
  <source>FEBS J.</source>
  <volume>281</volume>, 
  <fpage>4085</fpage>â€“
  <lpage>4096</lpage>. 
  <pub-id pub-id-type="doi">10.1111/febs.12936</pub-id>, PMID: 
  <?supplied-pmid 25039866?>
  <pub-id pub-id-type="pmid">25039866</pub-id>
 </mixed-citation>
</ref>
